2019
DOI: 10.1038/s41591-019-0521-4
|View full text |Cite
|
Sign up to set email alerts
|

GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis

Abstract: Cytokine dysregulation is a central driver of chronic inflammatory diseases such as multiple sclerosis (MS). Here we sought to determine the characteristic cellular and cytokine polarization profile in patients with relapsing-remitting multiple sclerosis (RRMS) by high-dimensional single-cell mass cytometry (CyTOF). Using a combination of neural network-based representation learning algorithms, we identified an expanded T helper cell subset in MS patients, characterized by the expression of GM-CSF and the C-X-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

13
146
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1
1

Relationship

2
8

Authors

Journals

citations
Cited by 144 publications
(160 citation statements)
references
References 69 publications
(76 reference statements)
13
146
1
Order By: Relevance
“…Further, IL‐17 and TNFα increased VCAM1 transcript in brain stem compared to spinal cord astrocytes (Figure 2c), while IFNγ highly upregulated CXCR7 in spinal cord astrocytes compared to those from the brain stem (Figure 2d). While granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) is also known to contribute to inflammation during EAE and MS (Galli et al, ; Kroenke et al, ; Pierson & Goverman, ; Rothhammer et al, ), we did not observe a significant regional difference in VCAM1 transcripts in astrocytes following GM‐CSF treatment (data not shown).…”
Section: Resultscontrasting
confidence: 59%
“…Further, IL‐17 and TNFα increased VCAM1 transcript in brain stem compared to spinal cord astrocytes (Figure 2c), while IFNγ highly upregulated CXCR7 in spinal cord astrocytes compared to those from the brain stem (Figure 2d). While granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) is also known to contribute to inflammation during EAE and MS (Galli et al, ; Kroenke et al, ; Pierson & Goverman, ; Rothhammer et al, ), we did not observe a significant regional difference in VCAM1 transcripts in astrocytes following GM‐CSF treatment (data not shown).…”
Section: Resultscontrasting
confidence: 59%
“…Granulocyte-macrophage colony-simulating factor (GM-CSF), originally identified as a hematopoietic growth factor has been recently identified as a prominent factor playing role in inflammation and autommunity [44,45]. This cytokine apparently plays an important role in the pathogenesis of MS, especially in modulation of myeloid cell function and potentially direct triggering of tissue destruction by these cells [46]. In our study, GM-CSF showed the most robust correlations with the lipoprotein subfractions, confirming its supposed role in the pathogenesis of MS.…”
Section: Discussionmentioning
confidence: 99%
“…S1. First, we performed an unbiased discovery approach with CellCnn, a neural network-based artificial intelligence algorithm allowing analysis of single-cell data and detection of cells associated with clinical status (28)(29)(30). During training, CellCnn learns combinations of weights for each marker in a given panel that best discriminate between groups of patients.…”
Section: Sars-cov2 Induces Phenotypic Changes In Circulating Immune Cmentioning
confidence: 99%